A carregar...

Targeted treatment of advanced and metastaticbreast cancer with lapatinib

Improved molecular understanding of breast cancer in recent years has led to the discovery of important drug targets such as HER-2 and EGFR. Lapatinib is a potent dual inhibitor of HER-2 and EGFR. Preclinical and phase I studies have shown activity with lapatinib in a number of cancers, including br...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Corkery, Brendan, O’Donovan, Norma, Crown, John
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2994213/
https://ncbi.nlm.nih.gov/pubmed/21127749
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!